In-home Intravesical Therapy: The Future of Nonmuscle-invasive Bladder Cancer Care Delivery?

No AccessJournal of UrologyJU Forum1 Apr 2023In-home Intravesical Therapy: The Future of Nonmuscle-invasive Bladder Cancer Care Delivery? Timothy D. Lyon, Stephen A. Boorjian, and Mark D. Tyson Timothy D. LyonTimothy D. Lyon *Correspondence: Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224 telephone: 904-953-2000; E-mail Address: [email protected] https://orcid.org/0000-0001-9251-3687 Department of Urology, Mayo Clinic, Jacksonville, Florida Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota More articles by this author , Stephen A. BoorjianStephen A. Boorjian Department of Urology, Mayo Clinic, Rochester, Minnesota More articles by this author , and Mark D. TysonMark D. Tyson Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota Department of Urology, Mayo Clinic, Phoenix, Arizona More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003176AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail REFERENCES 1. . Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976; 116(2):180-183. Link, Google Scholar 2. . Cancer statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. Crossref, Medline, Google Scholar 3. . Home bacillus Calmette-Guerin therapy for the treatment of superficial bladder cancer. Home Healthc Nurse. 1991; 9(5):50-52. Crossref, Medline, Google Scholar 4. . DH praise for home chemotherapy patient services may lead to pilot projects across England and Wales. Cancer Nurs Pract. 2006; 5(9):4. Crossref, Google Scholar 5. . A national cross-sectional survey of financial toxicity among bladder cancer patients. Urol Oncol. 2021; 39(1):76.e1-76.e7. Crossref, Medline, Google Scholar 6. . The home is the new cancer center. J Natl Compr Canc Netw. 2020; 18(10):1297-1299. Crossref, Medline, Google Scholar 7. . Accelerating the delivery of cancer care at home during the Covid-19 pandemic. NEJM Catal Innov Care Deliv. 2020; 4(1). Google Scholar 8. . Development of an innovative delivery system for bacillus Calmette-Guerin bladder administration. Am J Health Syst Pharm. 2021; 78(1):60-64. Crossref, Medline, Google Scholar 9. . Screening urine analysis before bacille Calmette-Guérin instillation does not reduce the rate of infectious complications. BJU Int. 2012; 109(12):1819-1821. Crossref, Medline, Google Scholar Support: None. Conflict of Interest: TDL has served as a consultant for Bristol Myers Squibb and ImmunityBio, and is supported by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. SAB has served as a consultant for Protara, Prokarium, FerGene, and Ferring. MDT has served as a consultant for Photocure and is supported by the Christian Haub Family Career Development Award for Cancer Research Honoring Dr. Richard Emslander and the Eric and Gail Blodgett Foundation. Ethics Statement: In lieu of a formal ethics committee, the principles of the Helsinki Declaration were followed. Data Availability: Data sharing not applicable to this article as no data sets were generated or analyzed during the current study. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue 4April 2023Page: 656-658 Peer Review Report Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.Keywordshome care servicesurinary bladder neoplasmsBCG vaccineadministration, intravesicalACKNOWLEDGMENTWe thank Tara Brigham, MLIS, AHIP, for her assistance with the literature search.MetricsAuthor Information Timothy D. Lyon Department of Urology, Mayo Clinic, Jacksonville, Florida Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota *Correspondence: Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224 telephone: 904-953-2000; E-mail Address: [email protected] More articles by this author Stephen A. Boorjian Department of Urology, Mayo Clinic, Rochester, Minnesota More articles by this author Mark D. Tyson Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota Department of Urology, Mayo Clinic, Phoenix, Arizona More articles by this author Expand All Support: None. Conflict of Interest: TDL has served as a consultant for Bristol Myers Squibb and ImmunityBio, and is supported by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. SAB has served as a consultant for Protara, Prokarium, FerGene, and Ferring. MDT has served as a consultant for Photocure and is supported by the Christian Haub Family Career Development Award for Cancer Research Honoring Dr. Richard Emslander and the Eric and Gail Blodgett Foundation. Ethics Statement: In lieu of a formal ethics committee, the principles of the Helsinki Declaration were followed. Data Availability: Data sharing not applicable to this article as no data sets were generated or analyzed during the current study. Advertisement PDF downloadLoading ...

Topic: Bladder and Urothelial Cancer Treatments
Subfield: Surgery
Field: Medicine
Domain: Health Sciences